BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 36310511)

  • 1. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
    Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
    J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
    Li J; Su T; Yang L; Zhang C; He Y
    Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
    Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
    Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
    Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
    Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
    Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
    [No Abstract]   [Full Text] [Related]  

  • 13. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
    Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
    J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
    Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
    Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.
    Ren J; Xu S; Guo D; Zhang J; Liu S
    Clin Transl Oncol; 2014 Jul; 16(7):668-74. PubMed ID: 24248895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
    Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
    World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Transcription Factor 7 (TCF7) as a Prognostic Factor in Gastric Cancer.
    Xu X; Liu Z; Tian F; Xu J; Chen Y
    Med Sci Monit; 2019 May; 25():3957-3963. PubMed ID: 31133633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
    Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
    BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.